Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:50 pm Sale | 13G | BELLEROPHON THERAPEUTICS INC C BLPH | PERCEPTIVE ADVISORS LLC | 0 0% | -930,000 (Position Closed) | View |
| 2024-02-14 4:49 pm Sale | 13G | ADMA BIOLOGICS INC ADMA | PERCEPTIVE ADVISORS LLC | 6,433,369 2.8% | -5,466,886 (-45.94%) | View |
| 2024-02-14 4:49 pm Unchanged | 13G | ORCHESTRA BIOMED HOLDINGS, INC OBIO | PERCEPTIVE ADVISORS LLC | 2,432,089 6.8% | 0 (Unchanged) | View |
| 2024-02-14 4:48 pm Purchase | 13G | ARCELLX INC ACLX | PERCEPTIVE ADVISORS LLC | 4,544,809 8.8% | 1,946,504 (+74.91%) | View |
| 2024-02-14 4:47 pm Purchase | 13G | VERRICA PHARMACEUTICALS INC VRCA | PERCEPTIVE ADVISORS LLC | 7,099,182 16.9% | 2,060,199 (+40.89%) | View |
| 2024-02-14 4:46 pm Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | PERCEPTIVE ADVISORS LLC | 4,024,400 3.5% | -1,254,562 (-23.77%) | View |
| 2024-02-14 4:46 pm Sale | 13G | LARIMAR THERAPEUTICS INC LRMR | PERCEPTIVE ADVISORS LLC | 0 0% | -2,860,000 (Position Closed) | View |
| 2024-02-14 4:44 pm Sale | 13G | ZYMEWORKS INC ZYME | PERCEPTIVE ADVISORS LLC | 1,074,807 1.5% | -3,436,468 (-76.18%) | View |
| 2024-02-14 4:41 pm Purchase | 13G | RAPT THERAPEUTICS INC RAPT | PERCEPTIVE ADVISORS LLC | 2,139,950 6.2% | 340,995 (+18.96%) | View |
| 2024-02-14 4:41 pm Purchase | 13G | CARGO THERAPEUTICS INC CRGX | PERCEPTIVE ADVISORS LLC | 3,436,600 8.3% | 190,432 (+5.87%) | View |
| 2024-02-14 4:40 pm Purchase | 13G | LEAP THERAPEUTICS INC LPTX | PERCEPTIVE ADVISORS LLC | 1,068,497 4% | 1,068,497 (New Position) | View |
| 2024-02-14 4:39 pm Purchase | 13D | MEIRAGTX HLDGS PLC MGTX | PERCEPTIVE ADVISORS LLC | 11,442,562 18% | 35,999 (+0.32%) | View |
| 2024-02-14 4:38 pm Purchase | 13G | ENVVENO MED CORP COM NVNO | PERCEPTIVE ADVISORS LLC | 1,394,716 9.9% | 457,201 (+48.77%) | View |
| 2024-02-14 4:38 pm Purchase | 13G | AMICUS THERAPEUTICS INC FOLD | PERCEPTIVE ADVISORS LLC | 28,057,456 9.6% | 414,539 (+1.50%) | View |
| 2024-02-14 4:36 pm Unchanged | 13G | ACRIVON THERAPEUTICS INC ACRV | PERCEPTIVE ADVISORS LLC | 3,007,858 13.6% | 0 (Unchanged) | View |
| 2024-02-14 4:36 pm Sale | 13G | AMYLYX PHARMACEUTICALS INC AMLX | PERCEPTIVE ADVISORS LLC | 1,869,125 2.8% | -4,219,208 (-69.30%) | View |
| 2024-02-14 4:34 pm Purchase | 13G | CELCUITY INC CELC | PERCEPTIVE ADVISORS LLC | 1,481,300 6.1% | 40,000 (+2.78%) | View |
| 2024-02-14 4:32 pm Sale | 13G | VERU INC VERU | PERCEPTIVE ADVISORS LLC | 5,584,699 3.8% | -2,273,312 (-28.93%) | View |
| 2024-02-14 4:31 pm Purchase | 13G | EVOLUS INC EOLS | PERCEPTIVE ADVISORS LLC | 3,963,424 6.9% | 876,820 (+28.41%) | View |
| 2024-02-14 4:29 pm Unchanged | 13D | LYRA THERAPEUTICS INC LYRA | PERCEPTIVE ADVISORS LLC | 12,757,563 24.3% | 0 (Unchanged) | View |